A Deadly Conundrum
How do you suppress the immune systems of children with leukemia who undergo a stem cell transplant to avoid rejection while activating that system to fight off relapses? Dr. Michel Duval is investigating this in his BioCanRx project.
Matchmaker, matchmaker, make me a match…
Jonathan Bramson’s lab at McMaster University had developed a new technology to produce immune cells that will attack multiple myeloma cells. Jean-Sébastien Delisle’s lab at the Université de Montréal had novel methods and capacity to manufacture human immune cells that target cancer cells and that persist for a long time in the body, providing sustained anti-cancer activity.
Letter to the BioCanRx Network Community
You have no doubt heard the news from the federal government that the Networks of Centres of Excellence (NCE) program will be phased out by 2023. This new fund will provide direct project funding to academic researchers and will not fund network activities. Entities like BioCanRx will not be eligible to apply.